AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Best Abstract Award

$250 grant.  Up to two awards will be given and will be announced at the
Division meeting during the AACC Annual Meeting.  To compete for this
award, you must:

  • Submit an abstract in the field of therapeutic drug management
    or toxicology
  • Be the presenting author of an accepted abstract for the
    upcoming AACC Annual Meeting

Abstract Winners

  • 2012: 
    Matt Petrie, D-149: UGT1A1*28 and UGT2B7*2 Polymorphisms do not Significantly Affect the Formation of Ethyl Glucuronide in vivo 
    John Wilson, D-140: Analysis of Commercial "Bath Salts" Blends by GC/MS

  • 2011: 
    Mark Borgman, B-10: Prospective Validation of Plasma S-Warfarin Concentration-Time Profiles Adjusted for CYP2C9 Genotype 
    Werner Steimer, B-43: Falsely Elevated Immunosuppressant Concentrations: Reversible Adsorption to a Variety of Central Venous Catheters

  • 2010: 
    Lindsay Hardy, E-70: Ethylene Glycol Screening: Adapting the CATACHEM Enzymatic Assay to Minimize False Positives 
    Roy Gerona, E-120: Clinical Utility of an LC-MS/TOF Seizure Panel in Emergency Department's Seizure Patients